Jingwen Wang

1.3k citations
61 papers · 635 indexed · h-index 13
Topics
Lymphoma Diagnosis and Treatment (16 papers)Viral-associated cancers and disorders (13 papers)Acute Myeloid Leukemia Research (7 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Jingwen Wang

51 papers receiving 630 citations

Peers

Jingwen Wang
Comparison fields: 5 of 83
  • Pathology and Forensic Medicine 190
  • Molecular Biology 179
  • Hematology 170
  • Pulmonary and Respiratory Medicine 121
  • Oncology 111
Replace Irmgard Andresen with:
Irmgard Andresen Germany
John Coucher Australia
Massimo Ragni Italy
Denise D’Andrea United States
Stefano Aterini Italy
Attila Pethö‐Schramm Switzerland
Constance C. F. M. J. Baaten Netherlands
Nobuo Negoro Japan
Jin Nakamura Japan
Othman Al‐Sawaf Germany
Jingwen Wang relative to Irmgard Andresen Germany Irmgard Andresen's profile →
Citations per field
00.5×4.1×
Irmgard Andresen · 1×
Citations per year

Countries citing papers authored by Jingwen Wang

Since Specialization
Citations

This map shows the geographic impact of Jingwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwen Wang more than expected).

Fields of papers citing papers by Jingwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwen Wang. The network helps show where Jingwen Wang may publish in the future.

Co-authorship network of co-authors of Jingwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwen Wang. A scholar is included among the top collaborators of Jingwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwen Wang. Jingwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 0
5 1
6 1
7 1
8 1
9 7
10 24
11 2
12 3
13 11
14 18
15 4
16 18
17 1
18 2
19 39
20 1

About Jingwen Wang

Jingwen Wang is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics, having authored 61 papers that have together received 635 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (13 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (170 citations), Pathology and Forensic Medicine (190 citations) and Biochemistry (36 citations). Jingwen Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Cong Li, Jianxin Xue, You Lü, Lei Deng, Feifei Na, Xiao‐Jun Huang, Luo Zhang, Liang Wang, Kailin Xu and Xin Du. Their work appears in journals such as Blood, Journal of Agricultural and Food Chemistry and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026